AV

Amit Verma

Director Director DIN 07416524
DIN 07416524 First appointment Feb 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Amit Verma

Data last updated:

Amit Verma was a Director at Alisir Plus Private Limited (2016–2019) and Director at Alisir Pharmaceuticals Private Limited (from 2017). The companies operate in Business Services.

DIN 07416524
Primary Designation Director
Industry Business Services
First Appointment 16 Feb 2016
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alisir Plus Private Limited U74900RJ2016PTC049318
Director16 Feb 20162016Active
Director26 Apr 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alisir Pharmaceuticals Private Limited
Alisir Plus Private Limited
Premium access

Shareholding and investment profile for Amit Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Verma

Amit Verma was first appointed on 16 Feb 2016 as Director at Alisir Plus Private Limited. The most recent appointment on record is 26 Apr 2017 at Alisir Pharmaceuticals Private Limited.

Amit Verma held 2 earlier board appointments: Alisir Plus Private Limited (Director, 16 Feb 2016 to 18 Jan 2019); Alisir Pharmaceuticals Private Limited (Director, from 26 Apr 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available